[go: up one dir, main page]

WO2003044160A3 - Molecules de la famille de proteines associees aux card et utilisations correspondantes - Google Patents

Molecules de la famille de proteines associees aux card et utilisations correspondantes Download PDF

Info

Publication number
WO2003044160A3
WO2003044160A3 PCT/US2002/025856 US0225856W WO03044160A3 WO 2003044160 A3 WO2003044160 A3 WO 2003044160A3 US 0225856 W US0225856 W US 0225856W WO 03044160 A3 WO03044160 A3 WO 03044160A3
Authority
WO
WIPO (PCT)
Prior art keywords
related protein
protein family
novel molecules
card related
card
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/025856
Other languages
English (en)
Other versions
WO2003044160A2 (fr
Inventor
John Bertin
Emad S Alnemri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thomas Jefferson University
Millennium Pharmaceuticals Inc
Original Assignee
Thomas Jefferson University
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/931,071 external-priority patent/US20020128219A1/en
Application filed by Thomas Jefferson University, Millennium Pharmaceuticals Inc filed Critical Thomas Jefferson University
Priority to AU2002364891A priority Critical patent/AU2002364891A1/en
Publication of WO2003044160A2 publication Critical patent/WO2003044160A2/fr
Publication of WO2003044160A3 publication Critical patent/WO2003044160A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des polypeptides, des protéines et des acides nucléiques associés aux domaines CARD-7 et CARD-8. Elle concerne aussi des procédés de diagnostic, de criblage et des méthodes thérapeutiques utilisant les compositions de l'invention.
PCT/US2002/025856 1999-10-27 2002-08-14 Molecules de la famille de proteines associees aux card et utilisations correspondantes Ceased WO2003044160A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002364891A AU2002364891A1 (en) 2001-08-15 2002-08-14 Novel molecules of the card related protein family and uses thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42825299A 1999-10-27 1999-10-27
US09/931,071 US20020128219A1 (en) 1999-10-27 2001-08-15 Novel molecules of the card related protein family and uses thereof
US09/931,071 2001-08-15

Publications (2)

Publication Number Publication Date
WO2003044160A2 WO2003044160A2 (fr) 2003-05-30
WO2003044160A3 true WO2003044160A3 (fr) 2003-09-12

Family

ID=27027684

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/025856 Ceased WO2003044160A2 (fr) 1999-10-27 2002-08-14 Molecules de la famille de proteines associees aux card et utilisations correspondantes

Country Status (1)

Country Link
WO (1) WO2003044160A2 (fr)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NAGASE ET AL.: "Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro", DNA RESEARCH, vol. 6, 1999, pages 63 - 70, XP001000446 *
RAZMARA ET AL.: "CARD-8 protein, a new CARD family member that regulates caspase-1 activated and apoptosis", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 277, no. 16, 19 April 2002 (2002-04-19), pages 13952 - 13958, XP002964853 *

Also Published As

Publication number Publication date
WO2003044160A2 (fr) 2003-05-30

Similar Documents

Publication Publication Date Title
WO1999038972A9 (fr) Genes humains et produits ii d'expression genique
NZ270659A (en) Mammalian protein which binds to a gst-fkbp-rapamycin complex, dna therefor and diagnostic compositions
CA2294516A1 (fr) Proteines ikk-.beta., acides nucleiques et procedes
WO1999058675A3 (fr) Genes humains et produits d'expression genique v
WO1999033982A3 (fr) Genes humains et produits d'expression genique i
EP1067182A3 (fr) Proteine secretoire ou proteine de membrane
WO2004047863A3 (fr) Produits geniques exprimes de maniere differentielle dans des tumeurs et leur utilisation
WO2002008285A3 (fr) Molecules il-17 et leurs utilisations
CA2295999A1 (fr) Proteines nik, acides nucleiques et procedes correspondants
WO2001023412A3 (fr) Procedes de criblage d'agents inhibiteurs de l'agregation des polypeptides
WO2001068705A3 (fr) Molecules du type recepteur de l'interleukine 17 et leurs utilisations
CA2336261A1 (fr) Genes et proteines cycline e2
WO2001042474A3 (fr) Molecules de type interferon et utilisations
WO2003016551A3 (fr) Proteine de liaison a l'acide salicylique codant des acides nucleiques, proteine de liaison a l'acide salicylique 2 (sabp2) et methodes d'utilisation associees
WO1999002704A3 (fr) Phosphatase a double specificite et procedes d'utilisation
WO2001012806A3 (fr) 'odorant-binding' proteines humaines fixant des ligands hydrophobes: polypeptides et polynucleotides codant lesdits polypeptides et leurs applications
WO2003027251A3 (fr) Nouvelles molecules de la famille des proteines du domaine de pyrine et leur utilisation
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO2001007479A3 (fr) Matieres vivantes et methodes utiles pour le diagnostic ou le traitement de maladies
WO2001074903A3 (fr) Molecules du type recepteur de cd20/ige et leurs applications
WO2001059120A3 (fr) Molecules de type il-17 et utilisation de ces dernieres
WO2000018916A3 (fr) Genes humains et produits d'expression genique
WO2003044160A3 (fr) Molecules de la famille de proteines associees aux card et utilisations correspondantes
WO2002062964A3 (fr) Variants d'amine oxydase ap1
WO2003033675A3 (fr) Identification de partenaires de liaison pour des proteines specifiques

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP